prnasiaJanuary 22, 2021
Tag: Elekta , ViewRay , Shares
Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. Elekta has no remaining shares in ViewRay after the transaction.
The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million, resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta's third quarter 2020/21.
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: